Value Added Technology (043150) Q2 2025 earnings summary

Executive summary

• Achieved consolidated revenue of KRW 110.6 billion in 2Q25, up 8.5% year-over-year and 9.2% sequentially, driven by expanded US sales and continued 3D product growth.

• Operates a global dental imaging business with 25 consolidated subsidiaries, focusing on digital X-ray and CT systems for dental applications, with a strong presence in North America, Europe, and Asia.

• Maintains a leading market position through continuous R&D, product innovation, and expansion into new markets and product lines, including AI-based diagnostic solutions.

• Recent strategic moves include the acquisition of full ownership of Vatech America Inc. and the launch of new high-resolution CT products targeting the North American market.

• Operating profit rose 0.2% year-over-year to KRW 16.9 billion, with margin at 15.3% (+2.2%p QoQ, -1.3%p YoY).

Financial highlights

• Consolidated revenue for H1 2025 was KRW 211.9 billion, with net income attributable to owners of KRW 19.6 billion and basic EPS of KRW 1,320.

• Gross profit margin was 50.4% in 2Q25, down 2.5%p YoY due to higher COGS from inflation; H1 2025 gross margin was approximately 51.6%.

• Net profit margin fell to 6.7% in 2Q25 from 14.8% a year ago; H1 2025 net margin was 9.0%.

• 3D (CBCT) products accounted for 58.9% of product sales, with 3.6% YoY growth; IOX and other products grew 17.1% YoY.

• Cash and cash equivalents at period end were KRW 81.8 billion.

Outlook and guidance

• Strategy focuses on expanding 3D premium and mid/entry product sales to capture market shift from 2D to 3D.

• Plans to strengthen market dominance through enhanced quality, technology, and customer service.

• Focus on expanding global market share through tailored marketing, customer education, and service programs.

• Continued investment in R&D to maintain technological leadership and respond to evolving clinical needs.